載入...

Clinicopathologic characteristics and outcomes of Chinese patients with non‐small‐cell lung cancer and BRAF mutation

BRAF mutation is one of the important driver oncogene in non‐small‐cell lung cancer (NSCLC). Data on Chinese patients with BRAF‐mutant NSCLC are inadequate. Hence, we conducted this study to investigate the clinicopathologic features and outcomes of Chinese patients with NSCLC and BRAF mutations. We...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Med
Main Authors: Ding, Xi, Zhang, Zengli, Jiang, Tao, Li, Xuefei, Zhao, Chao, Su, Bo, Zhou, Caicun
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5345676/
https://ncbi.nlm.nih.gov/pubmed/28135039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1014
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!